IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-45107-3.html
   My bibliography  Save this article

Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome

Author

Listed:
  • Brian Walitt

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Komudi Singh

    (Lung and Blood Institute (NHLBI))

  • Samuel R. LaMunion

    (Digestion, and Kidney Disease (NIDDK))

  • Mark Hallett

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Steve Jacobson

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Kong Chen

    (Digestion, and Kidney Disease (NIDDK))

  • Yoshimi Enose-Akahata

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Richard Apps

    (Autoimmunity, and Inflammation (CHI))

  • Jennifer J. Barb

    (NIH Clinical Center (CC))

  • Patrick Bedard

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Robert J. Brychta

    (Digestion, and Kidney Disease (NIDDK))

  • Ashura Williams Buckley

    (National Institute of Mental Health (NIMH))

  • Peter D. Burbelo

    (National Institute of Dental and Craniofacial Research (NIDCR))

  • Brice Calco

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Brianna Cathay

    (Texas A&M School of Engineering Medicine)

  • Li Chen

    (Affiliated Hospital of North Sichuan Medical College)

  • Snigdha Chigurupati

    (George Washington University Hospital, District of Columbia)

  • Jinguo Chen

    (Autoimmunity, and Inflammation (CHI))

  • Foo Cheung

    (Autoimmunity, and Inflammation (CHI))

  • Lisa M. K. Chin

    (NIH Clinical Center (CC))

  • Benjamin W. Coleman

    (Allegheny General Hospital)

  • Amber B. Courville

    (Digestion, and Kidney Disease (NIDDK))

  • Madeleine S. Deming

    (NIH Clinical Center (CC))

  • Bart Drinkard

    (NIH Clinical Center (CC))

  • Li Rebekah Feng

    (National Institute on Drug Abuse (NIDA))

  • Luigi Ferrucci

    (National Institute of Aging (NIA))

  • Scott A. Gabel

    (National Institute of Environmental Health Sciences (NIEHS))

  • Angelique Gavin

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • David S. Goldstein

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Shahin Hassanzadeh

    (Lung and Blood Institute (NHLBI))

  • Sean C. Horan

    (Sidney Kimmel Medical College)

  • Silvina G. Horovitz

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Kory R. Johnson

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Anita Jones Govan

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Kristine M. Knutson

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Joy D. Kreskow

    (National Institute of Nursing Research (NINR))

  • Mark Levin

    (Lung and Blood Institute (NHLBI))

  • Jonathan J. Lyons

    (National Institute of Allergy and Infectious Disease (NIAID))

  • Nicholas Madian

    (National Center for Complementary and Integrative Health (NCCIH))

  • Nasir Malik

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Andrew L. Mammen

    (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS))

  • John A. McCulloch

    (National Cancer Institute (NCI))

  • Patrick M. McGurrin

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Joshua D. Milner

    (Columbia University Medical Center)

  • Ruin Moaddel

    (National Institute of Aging (NIA))

  • Geoffrey A. Mueller

    (National Institute of Environmental Health Sciences (NIEHS))

  • Amrita Mukherjee

    (Autoimmunity, and Inflammation (CHI))

  • Sandra Muñoz-Braceras

    (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS))

  • Gina Norato

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Katherine Pak

    (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS))

  • Iago Pinal-Fernandez

    (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS))

  • Traian Popa

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Lauren B. Reoma

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Michael N. Sack

    (Lung and Blood Institute (NHLBI))

  • Farinaz Safavi

    (National Institute of Neurological Diseases and Stroke (NINDS)
    National Institute of Allergy and Infectious Disease (NIAID))

  • Leorey N. Saligan

    (National Institute of Nursing Research (NINR))

  • Brian A. Sellers

    (Autoimmunity, and Inflammation (CHI))

  • Stephen Sinclair

    (National Institute of Mental Health (NIMH))

  • Bryan Smith

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Joseph Snow

    (National Institute of Mental Health (NIMH))

  • Stacey Solin

    (NIH Clinical Center (CC))

  • Barbara J. Stussman

    (National Institute of Neurological Diseases and Stroke (NINDS)
    National Center for Complementary and Integrative Health (NCCIH))

  • Giorgio Trinchieri

    (National Cancer Institute (NCI))

  • Sara A. Turner

    (NIH Clinical Center (CC))

  • C. Stephenie Vetter

    (University of Colorado School of Medicine)

  • Felipe Vial

    (Clínica Alemana Universidad del Desarrollo)

  • Carlotta Vizioli

    (National Institute of Neurological Diseases and Stroke (NINDS))

  • Ashley Williams

    (Oakland University William Beaumont School of Medicine)

  • Shanna B. Yang

    (NIH Clinical Center (CC))

  • Avindra Nath

    (National Institute of Neurological Diseases and Stroke (NINDS))

Abstract

Post-infectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS) is a disabling disorder, yet the clinical phenotype is poorly defined, the pathophysiology is unknown, and no disease-modifying treatments are available. We used rigorous criteria to recruit PI-ME/CFS participants with matched controls to conduct deep phenotyping. Among the many physical and cognitive complaints, one defining feature of PI-ME/CFS was an alteration of effort preference, rather than physical or central fatigue, due to dysfunction of integrative brain regions potentially associated with central catechol pathway dysregulation, with consequences on autonomic functioning and physical conditioning. Immune profiling suggested chronic antigenic stimulation with increase in naïve and decrease in switched memory B-cells. Alterations in gene expression profiles of peripheral blood mononuclear cells and metabolic pathways were consistent with cellular phenotypic studies and demonstrated differences according to sex. Together these clinical abnormalities and biomarker differences provide unique insight into the underlying pathophysiology of PI-ME/CFS, which may guide future intervention.

Suggested Citation

  • Brian Walitt & Komudi Singh & Samuel R. LaMunion & Mark Hallett & Steve Jacobson & Kong Chen & Yoshimi Enose-Akahata & Richard Apps & Jennifer J. Barb & Patrick Bedard & Robert J. Brychta & Ashura Wil, 2024. "Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome," Nature Communications, Nature, vol. 15(1), pages 1-29, December.
  • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45107-3
    DOI: 10.1038/s41467-024-45107-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-45107-3
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-024-45107-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Christian Gaebler & Zijun Wang & Julio C. C. Lorenzi & Frauke Muecksch & Shlomo Finkin & Minami Tokuyama & Alice Cho & Mila Jankovic & Dennis Schaefer-Babajew & Thiago Y. Oliveira & Melissa Cipolla & , 2021. "Evolution of antibody immunity to SARS-CoV-2," Nature, Nature, vol. 591(7851), pages 639-644, March.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Haisheng Yu & Banghui Liu & Yudi Zhang & Xijie Gao & Qian Wang & Haitao Xiang & Xiaofang Peng & Caixia Xie & Yaping Wang & Peiyu Hu & Jingrong Shi & Quan Shi & Pingqian Zheng & Chengqian Feng & Guofan, 2023. "Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    2. Ramon Roozendaal & Laura Solforosi & Daniel J. Stieh & Jan Serroyen & Roel Straetemans & Anna Dari & Muriel Boulton & Frank Wegmann & Sietske K. Rosendahl Huber & Joan E. M. van der Lubbe & Jenny Hend, 2021. "SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques," Nature Communications, Nature, vol. 12(1), pages 1-10, December.
    3. Leire Campos-Mata & Benjamin Trinité & Andrea Modrego & Sonia Tejedor Vaquero & Edwards Pradenas & Anna Pons-Grífols & Natalia Rodrigo Melero & Diego Carlero & Silvia Marfil & César Santiago & Dàlia R, 2024. "A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity," Nature Communications, Nature, vol. 15(1), pages 1-13, December.
    4. Meriem Bekliz & Kenneth Adea & Pauline Vetter & Christiane S. Eberhardt & Krisztina Hosszu-Fellous & Diem-Lan Vu & Olha Puhach & Manel Essaidi-Laziosi & Sophie Waldvogel-Abramowski & Caroline Stephan , 2022. "Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    5. Lisa-Marie Funk & Gereon Poschmann & Fabian Rabe von Pappenheim & Ashwin Chari & Kim M. Stegmann & Antje Dickmanns & Marie Wensien & Nora Eulig & Elham Paknia & Gabi Heyne & Elke Penka & Arwen R. Pear, 2024. "Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    6. Grace Kenny & Sophie O’Reilly & Neil Wrigley Kelly & Riya Negi & Colette Gaillard & Dana Alalwan & Gurvin Saini & Tamara Alrawahneh & Nathan Francois & Matthew Angeliadis & Alejandro Abner Garcia Leon, 2023. "Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    7. Daniel M. Altmann & Catherine J. Reynolds & George Joy & Ashley D. Otter & Joseph M. Gibbons & Corinna Pade & Leo Swadling & Mala K. Maini & Tim Brooks & Amanda Semper & Áine McKnight & Mahdad Noursad, 2023. "Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity," Nature Communications, Nature, vol. 14(1), pages 1-9, December.
    8. Caitlin I. Stoddard & Kevin Sung & Zak A. Yaffe & Haidyn Weight & Guillaume Beaudoin-Bussières & Jared Galloway & Soren Gantt & Judith Adhiambo & Emily R. Begnel & Ednah Ojee & Jennifer Slyker & Dalto, 2023. "Elevated binding and functional antibody responses to SARS-CoV-2 in infants versus mothers," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    9. Héctor López-Mendoza & Antonio Montañés & F. Javier Moliner-Lahoz, 2021. "Disparities in the Evolution of the COVID-19 Pandemic between Spanish Provinces," IJERPH, MDPI, vol. 18(10), pages 1-20, May.
    10. Lei Peng & Yingxia Hu & Madeleine C. Mankowski & Ping Ren & Rita E. Chen & Jin Wei & Min Zhao & Tongqing Li & Therese Tripler & Lupeng Ye & Ryan D. Chow & Zhenhao Fang & Chunxiang Wu & Matthew B. Dong, 2022. "Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    11. Robert W. Aldridge & Alexei Yavlinsky & Vincent Nguyen & Max T. Eyre & Madhumita Shrotri & Annalan M. D. Navaratnam & Sarah Beale & Isobel Braithwaite & Thomas Byrne & Jana Kovar & Ellen Fragaszy & Wi, 2022. "SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    12. Maja Socan & Katarina Prosenc & Maja Mrzel, 2023. "Seroprevalence of Anti-SARS-CoV-2 Antibodies Following the Omicron BA.1 Wave," IJERPH, MDPI, vol. 20(4), pages 1-14, February.
    13. Lucie Bernard-Raichon & Mericien Venzon & Jon Klein & Jordan E. Axelrad & Chenzhen Zhang & Alexis P. Sullivan & Grant A. Hussey & Arnau Casanovas-Massana & Maria G. Noval & Ana M. Valero-Jimenez & Jua, 2022. "Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    14. Suad Hannawi & Linda Saf Eldin & Alaa Abuquta & Ahmad Alamadi & Sally A. Mahmoud & Aala Hassan & Shuping Xu & Jian Li & Dongfang Liu & Adam Abdul Hakeem Baidoo & Dima Ibrahim & Mojtaba Alhaj & Yuanxin, 2023. "Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men," Nature Communications, Nature, vol. 14(1), pages 1-9, December.
    15. Xiang Liu & Wern Hann Ng & Eva Zusinaite & Joseph Freitas & Adam Taylor & Venugopal Yerragunta & Shukra Madhaha Aavula & Sambaiah Gorriparthi & Santhakumar Ponsekaran & Rama Lakshmi Bonda & Priyanka M, 2024. "A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    16. Yubin Liu & Ziyi Wang & Xinyu Zhuang & Shengnan Zhang & Zhicheng Chen & Yan Zou & Jie Sheng & Tianpeng Li & Wanbo Tai & Jinfang Yu & Yanqun Wang & Zhaoyong Zhang & Yunfeng Chen & Liangqin Tong & Xi Yu, 2023. "Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    17. Marco Mandolesi & Hrishikesh Das & Liset Vries & Yiqiu Yang & Changil Kim & Manojj Dhinakaran & Xaquin Castro Dopico & Julian Fischbach & Sungyong Kim & Mariia V. Guryleva & Monika Àdori & Mark Cherny, 2024. "Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques," Nature Communications, Nature, vol. 15(1), pages 1-13, December.
    18. André Santa Cruz & Ana Mendes-Frias & Marne Azarias-da-Silva & Sónia André & Ana Isabel Oliveira & Olga Pires & Marta Mendes & Bárbara Oliveira & Marta Braga & Joana Rita Lopes & Rui Domingues & Ricar, 2023. "Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+β7 integrin+ T cells and anti-SARS-CoV-2 IgA response," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    19. Irene A. Abela & Chloé Pasin & Magdalena Schwarzmüller & Selina Epp & Michèle E. Sickmann & Merle M. Schanz & Peter Rusert & Jacqueline Weber & Stefan Schmutz & Annette Audigé & Liridona Maliqi & Anni, 2021. "Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity," Nature Communications, Nature, vol. 12(1), pages 1-18, December.
    20. Mark Chernyshev & Mrunal Sakharkar & Ruth I. Connor & Haley L. Dugan & Daniel J. Sheward & C. G. Rappazzo & Aron Stålmarck & Mattias N. E. Forsell & Peter F. Wright & Martin Corcoran & Ben Murrell & L, 2023. "Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages," Nature Communications, Nature, vol. 14(1), pages 1-12, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45107-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.